Charles River Laboratories International, Inc. Common Stock (NY:CRL)

290.19 +3.36 (+1.17%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

22 23 Next >

Gapping S&P500 stocks in Monday's session ↗

February 10, 2025

Let's have a look at the S&P500 gap up and gap down stocks in today's session.

Via Chartmill

Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call

January 28, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

What Analysts Are Saying About Charles River Stock ↗

January 23, 2025

Via Benzinga

This STMicroelectronics Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday ↗

January 22, 2025

Via Benzinga

Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences

January 21, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

This Spotify Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday ↗

January 17, 2025

Via Benzinga

Charles River and Akron Bio Announce Collaboration to Enhance Operations with Integration of CGMP Materials into Cell Therapy Platform

January 16, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

US Stocks Edge Higher As Traders Eye Inflation Data And Earnings Season Kickoff ↗

January 14, 2025

Wall Street saw a modest uptick on Tuesday as investors turned their focus to upcoming US inflation data following a better-than-expected producer price index (PPI) report.

Via Talk Markets

Topics Economy Stocks / Equities

Charles River Laboratories to Present at J.P. Morgan Healthcare Conference

January 13, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

P/E Ratio Insights for Charles River ↗

October 25, 2024

Via Benzinga

Evaluating Charles River: Insights From 12 Financial Analysts ↗

October 07, 2024

Via Benzinga

Charles River Introduces Global Biotech Incubator Program

December 05, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories to Present at Evercore ISI Investor Conference

December 02, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories to Present at UBS and Jefferies Conferences

November 11, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Q3 Earnings: CEO Notes Improved Biotech Funding And Stabilizing Demand - Here's Why ↗

November 06, 2024

Charles River Labs Q3 revenue of $1.01 billion surpassed expectations; however, revenue declined 1.6% YoY, and operating margin dropped to 11.6% amid restructuring costs.

Via Benzinga

The Analyst Verdict: Charles River In The Eyes Of 10 Experts ↗

September 20, 2024

Via Benzinga

S&P 500, Dow Hit Record Highs After Trump Win; Fear Index Drops 20% ↗

November 06, 2024

Market surges to record highs after Trump's election, Republicans win Senate majority. Tech and small-caps up, VIX drops 22%.

Via Benzinga

Topics Government Stocks

Charles River Laboratories Announces Third-Quarter 2024 Results

November 06, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

This Ferguson Enterprises Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

October 23, 2024

Via Benzinga

Charles River Launches New Retrogenix® Non-Human Protein Library

October 17, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call

October 16, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

This Alibaba Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗

October 07, 2024

Via Benzinga

This Netflix Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday ↗

October 07, 2024

Via Benzinga

Charles River Provides Translational Expertise at Neuroscience 2024

October 03, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica® to Advance the Discovery of Novel Drugs for Neurological Disease

October 02, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research

September 17, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Intel, Moderna And Dollar General Were Among Top 10 Large Cap Losers In August: Are The Others In Your Portfolio? ↗

September 08, 2024

10 worst performing large-cap stocks in August: Super Micro, Dollar General, Snap, PDD Holdings, Intel, Tencent Music, Gold Fields, Charles River, Moderna, Neurocrine Biosciences.

Via Benzinga

Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience

September 04, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

September 03, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Magnificent 7 Miss Out, 2 Cybersecurity Stocks Stand Firm, Retailers Lag In Volatile August: Here Are The Top S&P 500 Gainers And Losers ↗

August 31, 2024

The equity market was volatile in August, with the weakness seen early in the month dissipating amid a rise in rate-cut bets.

Via Benzinga

Topics Stocks

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.